Paroxetine mitigates cardiac remodelling by doxorubicin and increases survival
Doxorubicin (DOX) is an effective anticancer drug. However, its use is hampered by the development of very mortal cardiomyopathy. Here, we investigate whether the co-administration of the antidepressant paroxetine (P), known to exert beneficial cardiovascular effects, would provide effective cardiop...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Elsevier
2022
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ae3305f41fc244d78b45f5e1dcb8c74c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|